
{{header
 | title      = To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug. ( hr1285 ; 113th Congress)
 | author     = Vern Buchanan
 | translator = 
 | section    = 
 | previous   = 
 | next       = 
 | year       = 2013
 | month          = 03
 | day            = 20
 | notes      = ''{{USBill|113|hr|1285}}'' as introduced
 | categories =
 | portal     =
 | congress   = 113
 | session    = 1
 | title      = To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug. ( hr1285 ; 113th Congress)
 | bill       = 1285
 | billtype   = hr
 | purpose    = To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
}}

}}
113 HR 1285 IH: To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.U.S. House of Representatives2013-03-20text/xmlENPursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
{{Center|113th CONGRESS}}


{{Center|1st Session}}


{{Center|H. R. 1285}}


{{Center|IN THE HOUSE OF REPRESENTATIVES}}


{{Center|March 20, 2013}}


{{Center|
[[w:Vern Buchanan|Mr. Buchanan]] (for himself,
[[w:Ed Markey|Mr. Markey]] ,
[[w:Shelley Moore Capito|Mrs. Capito]] ,
[[w:Mario Diaz-Balart|Mr. Diaz-Balart]] ,
[[w:Jimmy Duncan (U.S. politician)|Mr. Duncan of Tennessee]] ,
[[w:John Mica|Mr. Mica]] ,
[[w:Phil Roe (politician)|Mr. Roe of Tennessee]] ,
[[w:Hal Rogers|Mr. Rogers of Kentucky]] ,
[[w:Tom Rooney (politician)|Mr. Rooney]] ,
[[w:Ileana Ros-Lehtinen|Ms. Ros-Lehtinen]] ,
[[w:Corrine Brown|Ms. Brown of Florida]] ,
[[w:Jim Cooper|Mr. Cooper]] ,
[[w:Donna Edwards|Ms. Edwards]] ,
[[w:Alcee Hastings|Mr. Hastings of Florida]] ,
[[w:William R. Keating|Mr. Keating]] ,
[[w:Stephen Lynch (politician)|Mr. Lynch]] ,
[[w:Nick Rahall|Mr. Rahall]] ,
[[w:Frederica Wilson|Ms. Wilson of Florida]] ,
[[w:Joseph P. Kennedy III|Mr. Kennedy]] ,
[[w:Patrick Murphy (Florida politician)|Mr. Murphy of Florida]] ,
[[w:Kathy Castor|Ms. Castor of Florida]] ,
[[w:Scott DesJarlais|Mr. DesJarlais]] ,
[[w:Stephen Fincher|Mr. Fincher]] ,
[[w:Jeff Miller (Florida politician)|Mr. Miller of Florida]] ,
[[w:Rich Nugent|Mr. Nugent]] ,
[[w:Pat Tiberi|Mr. Tiberi]] ,
[[w:Darrell Issa|Mr. Issa]] ,
[[w:Ted Deutch|Mr. Deutch]] ,
[[w:Bill Posey|Mr. Posey]] ,
[[w:Diane Black|Mrs. Black]] ,
[[w:Steve Pearce (politician)|Mr. Pearce]] ,
[[w:Tom Marino|Mr. Marino]] ,
[[w:Louise Slaughter|Ms. Slaughter]] ,
[[w:Lynn Westmoreland|Mr. Westmoreland]] ,
[[w:Steve Stivers|Mr. Stivers]] ,
[[w:Dan Benishek|Mr. Benishek]] ,
[[w:Ander Crenshaw|Mr. Crenshaw]] ,
[[w:Dennis A. Ross|Mr. Ross]] ,
[[w:Brian Higgins|Mr. Higgins]] ,
[[w:Steve Southerland (Florida politician)|Mr. Southerland]] ,
[[w:Scott Tipton|Mr. Tipton]] ,
[[w:Bill Shuster|Mr. Shuster]] ,
[[w:Candice Miller|Mrs. Miller of Michigan]] ,
[[w:Rodney L. Davis|Mr. Rodney Davis of Illinois]] , and
[[w:Aaron Schock|Mr. Schock]] ) introduced the following bill; which was referred to the [[w:United States House Committee on Energy and Commerce|Committee on Energy and Commerce]] , and in addition to the Committee on the [[w:United States House Committee on the Judiciary|Judiciary]] , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned}}


{{Center|A BILL}}

To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.

={{anchor|HAE84EA22D64A40F39FBCE51322182962}}Section 1. Hydrocodone amendment=



=={{anchor|HCDBE11CD53D3465F8A3E3E2E4729C27B}}(a) In general– ==

Schedule III(d) in section 202 of the Controlled Substances Act([http://www.law.cornell.edu/uscode/text// 21 U.S.C. 812] )is amended by—
:(1) striking paragraphs (3)and (4); and
:(2) redesignating paragraphs (5), (6), (7), and (8)as paragraphs (3), (4), (5), and (6), respectively.

=={{anchor|HC80D098BF72044739952FAAE5BA22C95}}(b) Effective date– ==

The amendments made by subsection (a)shall take effect on the date that is 6 months after the date of enactment of this Act.

={{anchor|HB7F1B90519D9485CB23C23FD12614A22}}Sec. 2. Physical security requirements=

Notwithstanding the amendments made by section 1, the [[w:United States Department of Justice|Attorney General]] shall immediately, without regard tochapter 5of title 5, United States Code, amend section 1301.72 of title 21, Code of Federal Regulations, relating to the physical security controls for non-practitioners, narcotic treatment programs and compounders for narcotic treatment programs, and storage areas for controlled substances, to allow, for the 3-year period beginning on the date of enactment of this Act, manufacturers and distributors to store hydrocodone compound products in accordance with the physical security requirements for schedule III, IV, and V controlled substances.

={{anchor|H372016F4F7B74037BE41276FC541AEBD}}Sec. 3. GAO report=



=={{anchor|H7C2E3A587D904B51A722E2823E0BB85A}}(a) In general– ==

Not later than 18 months after the date of enactment of this Act, the [[w:Government Accountability Office|Comptroller General of the United States]] shall submit to [[w:United States Congress|Congress]] a report on the reclassification of hydrocodone products under this Act.

=={{anchor|H1D45520BFA5A479B8C89BBEE7F77F8FF}}(b) Contents– ==

The report required under subsection (a)shall include—
:(1) an assessment of the degree to which the reclassification of hydrocodone products under this Act impacts the ability of patients with legitimate medical needs, particularly those in rural areas and nursing home facilities, to access adequate pain management; and
:(2) recommendations necessary to address issues, if any, relating to patient access to adequate pain management.